Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-24T08:26:45.487Z Has data issue: false hasContentIssue false

Uso de midazolán para anestesia de la TEC: efectos sobre la eficacia antidepresiva y la duración de la crisis. Hallazgos preliminares

Published online by Cambridge University Press:  12 May 2020

M. Auriacombe
Affiliation:
Grupo de Investigación de la TEC, Laboratorio de Psiquiatría, Universidad de Burdeos II, Centro Carreire, Hospital Charles Perrens, Burdeos, Francia
D. Grabot
Affiliation:
Grupo de Investigación de la TEC, Laboratorio de Psiquiatría, Universidad de Burdeos II, Centro Carreire, Hospital Charles Perrens, Burdeos, Francia
P. M. Lincheneau
Affiliation:
Grupo de Investigación de la TEC, Laboratorio de Psiquiatría, Universidad de Burdeos II, Centro Carreire, Hospital Charles Perrens, Burdeos, Francia
D. Zeiter
Affiliation:
Grupo de Investigación de la TEC, Laboratorio de Psiquiatría, Universidad de Burdeos II, Centro Carreire, Hospital Charles Perrens, Burdeos, Francia
J. Tignol
Affiliation:
Grupo de Investigación de la TEC, Laboratorio de Psiquiatría, Universidad de Burdeos II, Centro Carreire, Hospital Charles Perrens, Burdeos, Francia
Get access

Resumen

Midazolán es una benzodiacepina de acción corta que se ha utilizado para anestesia de la terapia electroconvulsiva (TEC). El propósito de este estudio era determinar sí el midazolán utilizado con este propósito deterioraría la eficacia antidepresiva de la TEC. En un estudio de asignación aleatoria doble ciego se comparó midazolán con metohexital sobre la eficacia antidepresiva de la TEC bilateral, medida por la reducción en las puntuaciones de la Escala de Evaluación de la Depresión de Montgomery Asberg (MADRS) y la duración de la crisis. Se incluyeron 16 pacientes con trastorno depresivo mayor del DSM-III-R con melancolía. Midazolán y metohexital no diferían en sus efectos sobre la puntuación de la MADRS o la duración de la crisis; no se encontró correlación entre la duración de la crisis y la evolución de la depresión para ninguno de los dos grupos. Nuestros hallazgos preliminares no apoyan la afirmación de que no se deben utilizar benzodiacepinas durante la TEC bilateral.

Type
Informe de caso
Copyright
Copyright © European Psychiatric Association 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. The Practice of ECT: recommendations for practice, training and privileging. Task Force Report on ECT. Washington, DC: American Psychiatric Press, 1990, French translation: Tignol, J, Auriacombe, M, La pratique de TElectroconvulsivothérapie. Paris: Manson, 1994.Google Scholar
Auriacombe, M, Tignol, J. Electroconvulsivothérapie et benzodiazépines: antagonisme ou indifférence? Encephale 1991; 17: 537–41.Google Scholar
Delbrouck, P, Caillard, V. L’électro-convulsivo-thérapie publique française (enquête 1988). Psychiatr Psychobiol 1990; 5: 381–6.Google Scholar
Delmas-Marsalet, P. L’électro-choc par courant continu. Cr Soc Biol 1942; 136: 551–3.Google Scholar
Delmas-Marsalet, P. Electrochoc et thérapeutiques nouvelles en neuropsychiatrie. Paris: Ballières, 1946.Google Scholar
Dwyer, R, McCaughey, W, Lavery, J, McCarthy, G, Dundee, W. Comparison of propofol and methohexitane as anesthetic agents for electroconvulsive therapy. Anaesthesia 1988; 43: 459–62.CrossRefGoogle Scholar
Fink, M. Electrode placement: a clinician's guide. Convulsive Ther 1990; 6: 263–5.Google ScholarPubMed
Fink, M, Johnson, L. Monitoring the duration of electro-convulsive therapy seizures. Am J Psychiatry 1982; 139: 1189–91.Google Scholar
Gaines, GY, Rees, DI. Electroconvulsive therapy and anesthetic considerations. Anesth Analg 1986; 65: 1345–56.CrossRefGoogle ScholarPubMed
Grabot, D, Lincheneau, PM, Auriacombe, M, Tignol, J. Mémoire et ECT. Joint annual meeting of the Société de Psychologie de Bordeaux et du Sud-Ouest, and the Société Française de Psychologie; Bordeaux, May 1990.Google Scholar
Greenblatt, M, Shader, RI, Abernethy, DR. Current status of benzodiazepines. N Engl J Med 1983; 309: 354–8, 410-16.Google ScholarPubMed
Guelfi, JD, Bobon, D. Echelles d’evaluation en psychiatrie. In: Moreau, L, ed. Encyclopédie Médico-Chirurgicale, Psychiatrie. Paris: Editions Techniques, (37200 A 10), 1989.Google Scholar
Guze, BH, Liston, EH, Baxter, LR Jr. Poor interrater reliability of MECTA EEG recordings of ECT seizure duration. J Clin Psychiatry 1989; 50: 140–2.Google ScholarPubMed
Lemperière, T. Comparaisons de différents instruments d’évaluation de la dépression à I'occasion d’une étude sur l ‘Athymil 30 mg. Ann Med Psychol 1984; 142: 1206–12.Google Scholar
Loo, H, Colonna, L, Petit, M, Benyacoub, A, Boulenger, JP. Electrochoc. In: Moreau, L, ed. Encyclopédie Médico-Chirurgicale, Psychiatrie. Paris: Editions Techniques, (37820 E 10), 1979.Google Scholar
Miller, AL, Faber, RA, Hach, JP, Alexander, HE. Factors affecting amnesia, seizure duration and efficacy in ECT. Am J Psychiatry 1985; 142: 692–96.Google ScholarPubMed
Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–9.CrossRefGoogle ScholarPubMed
Nettelbladt, P. Factors influencing number of treatment and seizure duration in ECT: drug treatment, social class. Convulsive Ther 1988; 4: 160–8.Google Scholar
Olessen, AC, Lolk, A, Christensen, P. Effects of a single night-time dose of oxazepam on seizure duration in electroconvulsive therapy. Convulsive Ther 1989; 5: 37.Google Scholar
Ottoson, JO. Use and misuse of electroconvulsive treatment. Biol Psychiatry 1985; 20: 933–46.CrossRefGoogle Scholar
Pellet, J, Decrat, M, Lang, Fet al. Description d’un échantillon de 300 échelles MADRS portant sur des sujets déprimés. Ann Med Psychol 1987; 145: 170–5.Google Scholar
Pettinati, HM, Stephens, SM, Willis, KM, Robin, SE. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psychiatry 1990; 147: 1029–35.Google ScholarPubMed
Price, TRP, McAllister, TW. Response of depressed patients to sequential unilateral nondominant brief pulse and sinusoidal ECT. J Clin Psychiatry 1986; 47: 182–6.Google ScholarPubMed
Rampton, AJ, Griffin, RM, Stuart, CS, Durcan, JJ, Huddy, NC, Abbott, MA. Comparison of methohexital and propofol for electroconvulsive therapy: effects on hemodynamic responses and seizure duration. Anesthesiology 1989; 70: 412–17.CrossRefGoogle ScholarPubMed
Reves, JG, Fragen, RJ, Vinik, HR, Greenblatt, DG. Midazolam: pharmacology and uses. Anaesthesiology 1985; 62: 310–24.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists. The practical administration of electroconvulsive therapy (ECT). London: Gaskel, 1989.Google Scholar
Sackeim, HA, Decima, P, Prohovnik, I. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiat 1983; 18: 1301–10.Google ScholarPubMed
Scharf, MB, Fletcher, K, Graham, JP. Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiatry 1988; 49: 134–7.Google ScholarPubMed
Squire, LR. Memory function as affected by electroconvulsive therapy. Ann NY Acad Sci 1986; 426: 307–14.CrossRefGoogle Scholar
Standish-Barry, HM, Deacon, V, Snaith, RP. The relationship of concurrent benzodiazepine administration to seizure duration in ECT. Acta Psychiat Scand 1985; 71: 269–71.CrossRefGoogle ScholarPubMed
Stromgren, LS, Fjeldborg, JON, Thomsen, A. Factors influencing seizures applied in unilateral electroconvulsive therapy. Acta Psychiat Scand 1980; 62: 158–65.Google ScholarPubMed
Taylor, JL, Tinklenberg, JR. Cognitive impairment and benzodiazepines. In: Meltzer, HY, ed. Psychopharmacology: The third generation of progress. New York: Raven Press, 1987; 1449-54.Google Scholar